Prospective study of 1 surgeon's experience with 115 cases using the Unfolder lens injection system

J Cataract Refract Surg. 2001 Sep;27(9):1437-9. doi: 10.1016/s0886-3350(01)00796-9.

Abstract

Purpose: To describe the experience of 1 surgeon's first 115 cases using the Allergan Unfolder intraocular lens (IOL) injection system.

Setting: Free-standing day-surgery center, Chatswood, Australia.

Methods: After standard phacoemulsification, an SI-40NB IOL (Allergan) was implanted using the Unfolder. Data on complications and the success of implantation were collected prospectively.

Results: Ninety-four percent of patients achieved a 1 month visual acuity of 6/6 or better. Of the 13 cases with a potential complication related to the Unfolder, all achieved a visual acuity of 6/6 or better. No complication affected the eye adversely or reduced visual acuity significantly.

Conclusion: Implantation of SI-40NB IOLs with the Unfolder led to no serious complications and gave satisfactory visual results.

MeSH terms

  • Humans
  • Intraoperative Complications
  • Lens Implantation, Intraocular / instrumentation*
  • Lenses, Intraocular*
  • Phacoemulsification*
  • Postoperative Complications
  • Prognosis
  • Prospective Studies
  • Visual Acuity